TABLE 3.

Clinical outcomes^g

Outcome	No. of events/no. of patients (%)		P value	Unadjusted OR (95% CI)	Adjusted OR (95% CI)
	Strong biofilm producers	Weak biofilm producers
Mortality
30 day	3/47 (6.4)	18/74 (24.3)	0.01	0.21 (0.06–0.77)	0.32 (0.08–1.26)a
90 day	6/47 (12.8)	27/74 (36.5)	0.004	0.25 (0.10–0.68)	0.36 (0.12–1.06)a
(Re)admission
30 day	11/45 (24.4)	17/61 (27.9)	0.69	0.84 (0.35–2.02)	1.65 (0.58–4.65)b
90 day	20/43 (46.5)	23/57 (40.3)	0.54	1.28 (0.58–2.86)	5.43 (1.69–17.4)c
MRSA (re)infection
30 day	3/47 (6.4)	8/66 (12.1)	0.36	0.49 (0.12–1.97)	0.33 (0.08–1.37)d
90 day	8/45 (17.8)	14/58 (24.1)	0.43	0.68 (0.26–1.80)	0.74 (0.25–2.18)e
MRSA-related (re)admission
30 day	5/44 (11.4)	8/61 (13.1)	0.79	0.85 (0.26–2.80)	1.20 (0.34–4.25)f
90 day	8/43 (18.6)	9/57 (15.8)	0.71	1.22 (0.43–3.47)	1.75 (0.56–5.45)f

^aAdjusted for hospitalization during previous 90 days for >2 days and admission type (inpatient or outpatient setting).

^bAdjusted for hospitalization during previous 90 days for >2 days and infection with confirmed bacteremia at the time that the index sample was cultured.

^cAdjusted for hospitalization during previous 90 days for >2 days, MLST CC5, serum creatinine concentration, and infection with confirmed pneumonia at the time that the index sample was cultured.

^dAdjusted for pigmentation.

^eAdjusted for MLST CC5 and pigmentation.

^fAdjusted for hospitalization during previous 90 days for >2 days.

^gAbbreviations: OR, odds ratio; CI, confidence interval; ICU, intensive care unit; BMI, body mass index.